Viewing Study NCT01458366


Ignite Creation Date: 2025-12-24 @ 4:03 PM
Ignite Modification Date: 2026-01-28 @ 3:55 AM
Study NCT ID: NCT01458366
Status: COMPLETED
Last Update Posted: 2025-04-30
First Post: 2011-09-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide
Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Hodgkin's Lymphoma View
None Lymphoma View
None B-Cell Lymphoma View